COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES
RAPT Therapeutics Reports First Quarter 2022 Financial Results
May 11, 2022
« back to news page